leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 00:52:28 - browse：73712

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Transgender sports debate: Physicians say bans are health issue

entertainment

knowledge

WSS

DeepMind touts AlphaFold's new skills as protein folding AI models face off

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

FDA panel to weigh safety of artificial wombs for preterm births

How the messy conversation about Dolly changed bioethics

Key Senate panel to consider PBM, drug pricing reform package

House panel takes first step toward fixing drug shortages

Wikipedia

leisure time

leisure time

Walensky prepares to leave CDC — and Congress — behind

People with substance use disorder deserve online privacy

Psychedelics group wrestles with new pharma identity

Midwives could help bridge maternal health disparities in the U.S.

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Coloradans with cystic fibrosis could lose access to Trikafta

Dobbs anniversary: the lost opportunity of abortion as health care

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Moonlake's readout produced a cash windfall. Risks remain

How the messy conversation about Dolly changed bioethics

explore

David Liu startup to focus on CRISPR delivery

FDA panel to weigh safety of artificial wombs for preterm births

Neurocrine congenital adrenal hyperplasia trial succeeds

Medicare proceeds with plan to claw back hospital funds

Coloradans with cystic fibrosis could lose access to Trikafta

Brain injuries and the importance of a second opinion

entertainment

Wikipedia

knowledge

explore